Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination.
about
Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis.Rotavirus vaccines: development and use for the prevention of diarrhoeal disease.Development, characterization, and diagnostic applications of monoclonal antibodies against bovine rotavirusRotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes.Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988.The antigenic diversity of rotaviruses: significance to epidemiology and vaccine strategies.Rotavirus diarrhea severity is related to the VP4 type in Mexican children.Rotavirus vaccines: an overview.Survey on the distribution of the gene 4 alleles of human rotaviruses by polymerase chain reaction.Human viral gastroenteritis.Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers.Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infectionVP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection.Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirusPolypeptide composition of rotavirus empty capsids and their possible use as a subunit vaccine.Why does the world need another rotavirus vaccine?Rotavirus-specific protein synthesis is not necessary for recognition of infected cells by virus-specific cytotoxic T lymphocytesComplete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopesDiarrheal response of gnotobiotic pigs after fetal infection and neonatal challenge with homologous and heterologous human rotavirus strains.Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigenRotavirus gene structure and function.Identification of a group-reactive epitope of group B rotaviruses recognized by monoclonal antibody and application to the development of a sensitive immunoassay for viral characterization.Relative frequencies of rotavirus serotypes 1, 2, 3, and 4 in Venezuelan infants with gastroenteritisComparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.Monoclonal antibody assay for detection of double-stranded RNA and application for detection of group A and non-group A rotavirusesReactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challengeClinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection.Chimeric recombinant rotavirus-like particles as a vehicle for the display of heterologous epitopes.Neutralizing antibodies to heterologous animal rotavirus serotypes 5, 6, 7, and 10 in sera from Ecuadorian children.Evaluation of a latex agglutination kit (Virogen Rotatest) for detection of bovine rotavirus in fecal samples.Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope.Development, evaluation, and application of lateral-flow immunoassay (immunochromatography) for detection of rotavirus in bovine fecal samplesMolecular biology of rotaviruses. VIII. Quantitative analysis of regulation of gene expression during virus replication.Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigenic variants.Isolation of an avianlike group A rotavirus from a calf with diarrhea.Protection of agammaglobulinemic piglets from porcine rotavirus infection by antibody against simian rotavirus SA-11.Interspecies transmission of rotaviruses studied from the perspective of genogroup.
P2860
Q33228744-5015AD31-D2B0-41F0-932B-DECEB14AE20EQ33603410-3E124992-B3F8-4116-A4A0-3F9549997132Q33998268-AAECD803-C05B-4D93-B99B-4FDD829FBF52Q34347258-5D28522F-8346-4300-A971-DCF438D0B599Q34456851-A570E999-BF93-4D01-A94F-B4DBDB91CDD4Q34553936-826BF5D4-1005-496C-AED6-053CC15F8C06Q35155896-96E80882-4B9C-4098-8CDA-1EF00D5557AEQ35371774-98AD160E-6794-4EDF-AFDA-EE7EDED91C98Q36504213-CF122A68-E126-415D-823B-AAFA9415BF5EQ36634738-EA60EA60-EBAC-4A88-A830-D8CEA9C510EFQ36656398-ADB5183E-2F77-4603-ADBB-CF7BFDD3A5F3Q36682098-03AB22F6-18EC-4AE4-B49A-C053FB4DF07CQ36694578-6B68D204-38FA-4C06-B49C-9ECD66B2945FQ36799538-C3A90B49-A0B0-4AB8-A98A-8A53806F8A16Q36811869-8AB8C521-E1A0-4A72-BC95-28D173941ADDQ36822928-6EE349FB-E651-4E01-9E59-34AF2D7C499EQ36829727-CB22C7C5-A3F8-48C8-A726-BF838259EE17Q36830849-1FC50588-BABC-415E-B7BA-22D38D2C05B0Q36871139-F038096A-BD90-4F8A-A334-079C56A081F9Q36871958-CE9F1190-AD5D-44A0-8C29-6BE38BB2994BQ36875550-B89CC3D9-26EF-4D9E-94EF-1B9F415CF662Q37055891-D81B1116-8206-4AFC-A35B-B3F0FBBC1181Q37154280-4A712B8B-E8DD-4696-9E46-27E63DE4F473Q37156618-EF1BA696-8607-4A89-8870-1E58EC3C446AQ37164301-F5DC79B6-7D3D-49BD-9D2C-D653345B3F4EQ37166863-7569BF33-51BF-48B0-A66A-5DA43EA0C748Q37169945-33FB2F5A-4AAB-47B1-ABAB-C1D163648EF2Q37172595-89F0F82C-240A-4BF0-92BA-5D647672BADFQ37228110-4B628220-83F2-49D6-AC40-2BDEB6559E8AQ37399901-2D515845-761E-4B77-A7E5-252B1220F3F9Q37422406-A52AFC0A-9FF0-422C-BDB3-79B1B1B179B9Q39242930-A2C0511C-4AE6-4381-8D87-5E43196E9CAAQ39508206-63A03049-FEC4-48D5-B7C3-7531DBA155EBQ39605646-692EAB1F-232B-4590-AEFF-EDE258DC99E9Q39625804-C6357FE3-6ABD-4B8B-986A-FE6C7C067C9AQ40115004-F25E1FD3-8721-4EFB-BF67-B58E9C1AE986Q40132455-B0FC2675-8FCA-4208-86FA-76D9213BB5BEQ40184953-B17649C2-6320-48DD-8D28-456454076BB8Q40212910-8EB866C9-DAD5-43A9-AC51-94A6CDA79A78Q40489158-9425AE6E-95C0-42B4-A5FD-723AAB33B2DE
P2860
Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Rotavirus: the major etiologic ...... rian" approach to vaccination.
@en
Rotavirus: the major etiologic ...... rian" approach to vaccination.
@nl
type
label
Rotavirus: the major etiologic ...... rian" approach to vaccination.
@en
Rotavirus: the major etiologic ...... rian" approach to vaccination.
@nl
prefLabel
Rotavirus: the major etiologic ...... rian" approach to vaccination.
@en
Rotavirus: the major etiologic ...... rian" approach to vaccination.
@nl
P2093
P356
P1476
Rotavirus: the major etiologic ...... rian" approach to vaccination.
@en
P2093
Chanock RM
Gorziglia M
Kapikian AZ
P304
P356
10.1093/INFDIS/153.5.815
P407
P577
1986-05-01T00:00:00Z